BRPI1007295A - peptídeos antibióticos - Google Patents

peptídeos antibióticos

Info

Publication number
BRPI1007295A
BRPI1007295A BRPI1007295A BRPI1007295A BR PI1007295 A BRPI1007295 A BR PI1007295A BR PI1007295 A BRPI1007295 A BR PI1007295A BR PI1007295 A BRPI1007295 A BR PI1007295A
Authority
BR
Brazil
Prior art keywords
antibiotic peptides
antibiotic
peptides
Prior art date
Application number
Other languages
English (en)
Inventor
Anna Klara Brigitte Hansen
Daniel Knappe
Ralf Hoffmann
Original Assignee
Amp Therapeutics Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amp Therapeutics Gmbh & Co Kg filed Critical Amp Therapeutics Gmbh & Co Kg
Publication of BRPI1007295A publication Critical patent/BRPI1007295A/pt
Publication of BRPI1007295A8 publication Critical patent/BRPI1007295A8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/40Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
    • A01N47/42Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
    • A01N47/44Guanidine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
BRPI1007295A 2009-01-29 2010-01-29 peptídeos antibióticos BRPI1007295A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009007381A DE102009007381A1 (de) 2009-01-29 2009-01-29 Antibiotische Peptide
PCT/EP2010/051072 WO2010086401A1 (de) 2009-01-29 2010-01-29 Antibiotische peptide

Publications (2)

Publication Number Publication Date
BRPI1007295A true BRPI1007295A (pt) 2016-02-02
BRPI1007295A8 BRPI1007295A8 (pt) 2016-08-09

Family

ID=42124600

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1007295A BRPI1007295A8 (pt) 2009-01-29 2010-01-29 peptídeos antibióticos

Country Status (14)

Country Link
US (3) US8686113B2 (pt)
EP (1) EP2391636B1 (pt)
JP (1) JP2012516142A (pt)
KR (1) KR20110120917A (pt)
CN (1) CN102369210A (pt)
AU (1) AU2010209695A1 (pt)
BR (1) BRPI1007295A8 (pt)
CA (1) CA2751010A1 (pt)
DE (1) DE102009007381A1 (pt)
IL (1) IL214365A0 (pt)
MX (1) MX2011008030A (pt)
RU (1) RU2011135755A (pt)
WO (1) WO2010086401A1 (pt)
ZA (1) ZA201105852B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8937155B2 (en) 2010-05-28 2015-01-20 Amp Therapeutics Gmbh Antimicrobial peptides and peptide derivatives derived from Oncopeltus fasciatus
DE102011118029A1 (de) 2011-06-20 2012-12-20 Universität Leipzig Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung
CN102276691B (zh) * 2011-08-04 2013-03-13 东北农业大学 一种抗菌肽及其制备方法
BR112014003340B1 (pt) * 2011-08-12 2021-05-18 Atlantic Industries Limited chapa de metal corrugada e estrutura elevada incorporando a mesma
WO2013041663A2 (de) * 2011-09-22 2013-03-28 Amp-Therapeutics Gmbh Modifizierte apidaecinderivate als antibiotische peptide
WO2013064633A1 (de) 2011-11-04 2013-05-10 Amp-Therapeutics Gmbh Oncopeltus-peptidderivate als antimikrobielle peptide
US20130325121A1 (en) * 2012-05-31 2013-12-05 Clemson University Protein based materials, plastic albumin devices and related methods
WO2014039013A1 (en) * 2012-09-07 2014-03-13 Agency Of Science, Technology And Research Tetrabranched peptides and analogues as a new class of antimicrobials and their preparation thereof
US9273093B2 (en) * 2012-10-11 2016-03-01 Protagonist Therapeutics, Inc. α4β7 peptide dimer antagonists
KR20140088837A (ko) * 2013-01-03 2014-07-11 한미약품 주식회사 N-말단 전하가 변형된 인슐린 분비 펩티드 유도체
HK1217898A1 (zh) * 2013-02-22 2017-01-27 纽约市哥伦比亚大学理事会 通過抑制轉錄因子atf5來抑制腫瘤細胞的組合物和方法
RS62633B1 (sr) 2013-03-15 2021-12-31 Protagonist Therapeutics Inc Analozi hepcidina i njihove primene
FR3005963B1 (fr) * 2013-05-24 2016-02-26 Centre Nat Rech Scient Bacterie isolee du genre pseudoalteromonas, cyclolipopeptides, et leurs utilisations
US10266566B2 (en) 2013-07-15 2019-04-23 North Carolina State University Protease-resistant peptide ligands
SI3143037T1 (sl) 2014-05-16 2021-11-30 Protagonist Therapeutics, Inc. Antagonisti integrin alpha4beta7 tioeterskih peptidov
CN107206254B (zh) 2014-07-17 2021-08-24 领导医疗有限公司 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途
US9029319B1 (en) * 2014-08-04 2015-05-12 Centaur, Inc. Water buffalo derived peptide antibiotic therapies
WO2016054411A1 (en) 2014-10-01 2016-04-07 Protagonist Therapeutics, Inc. NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS
WO2016054445A1 (en) 2014-10-01 2016-04-07 Protagonist Therapeutics, Inc. Novel cyclic monomer and dimer peptides having integrin antagonist activity
RU2566554C1 (ru) * 2015-01-12 2015-10-27 Федеральное бюджетное учреждение науки "Ростовский научно-исследовательский институт микробиологии и паразитологии" (ФБУН РостовНИИ микробиологии и паразитологии) ШТАММ Stenotrophomonas maltophilia, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ АНТИГЕНА ДЛЯ ОПРЕДЕЛЕНИЯ АНТИТЕЛ К Stenotrophomonas maltophilia В БИОЛОГИЧЕСКИХ СРЕДАХ
US10787490B2 (en) 2015-07-15 2020-09-29 Protaganist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
CA3009834A1 (en) 2015-12-30 2017-07-06 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
WO2017165676A1 (en) 2016-03-23 2017-09-28 Protagonist Therapeutics, Inc. METHODS FOR SYNTHESIZING α4β7 PEPTIDE ANTAGONISTS
CN113521007B (zh) * 2016-07-01 2022-11-18 四川大学 抗菌肽衍生物在制备免疫佐剂中的用途
EP4092038A1 (en) 2017-09-11 2022-11-23 Protagonist Therapeutics, Inc. Opioid agonist peptides and uses thereof
EP4501952A3 (en) 2018-02-08 2025-04-16 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
EP3820883A4 (en) 2018-07-12 2022-04-20 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
CN108864270B (zh) * 2018-07-19 2021-03-30 四川理工学院 一种白蚁抗菌肽及其应用
CN116082455A (zh) 2019-07-10 2023-05-09 领导医疗有限公司 白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途
EP4090669A4 (en) 2020-01-15 2024-11-20 Janssen Biotech, Inc. PEPTIDE INHIBITORS OF THE INTERLEUKIN-23 RECEPTOR AND THEIR USE IN TREATING INFLAMMATORY DISEASES
SI4090670T1 (sl) 2020-01-15 2025-08-29 Janssen Biotech, Inc. Peptidni zaviralci receptorja interlevkina-23 in njihova uporaba za zdravljenje vnetnih bolezni
IL316550A (en) 2020-11-20 2024-12-01 Janssen Pharmaceutica Nv Compositions of interleukin-23 receptor peptide inhibitors
CA3173504A1 (en) * 2020-12-15 2022-06-23 Dietrich A. Stephan Oligonucleotide analogue therapeutics for treatment of neuromuscular disease
CN113549137B (zh) * 2021-07-09 2022-04-19 东北农业大学 一种靶向革兰氏阴性菌的富脯氨酸抗菌肽Pyr-2及其制备方法与应用
IL310061A (en) 2021-07-14 2024-03-01 Janssen Biotech Inc Peptide inhibitors linked to fatty residues of the interleukin-23 receptor
CN116789740B (zh) * 2023-06-25 2025-04-01 黑龙江八一农垦大学 一种细胞穿透肽、入胞抗菌肽及其应用
CN118047841B (zh) * 2024-04-09 2024-06-11 中国农业科学院农业基因组研究所 一种发酵桑叶抗菌肽Squ8及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028A (en) * 1847-03-20 monohot
EP0299828B1 (en) 1987-07-01 1994-06-15 Plant Genetic Systems N.V. Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications
US5466671A (en) 1994-03-02 1995-11-14 Sloan-Kettering Institute For Cancer Research Apidaecin-type peptide antibiotics with improved activities and/or different antibacterial spectrum
WO2000078956A1 (en) 1999-06-23 2000-12-28 The Wistar Institute Of Anatomy And Biology Novel pyrrhocoricin-derived peptides, and methods of use thereof
US20030104622A1 (en) * 1999-09-01 2003-06-05 Robbins Paul D. Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
US20020041898A1 (en) 2000-01-05 2002-04-11 Unger Evan C. Novel targeted delivery systems for bioactive agents
WO2002079467A2 (en) * 2001-03-29 2002-10-10 Københavns Universitet Antibiotic-free bacterial strain selection with antisense molecules
AU2003216091A1 (en) 2002-01-22 2003-09-02 Intrabiotics Pharmaceuticals, Inc. Hybrid synthetic method for antimicrobial peptides
WO2003079997A2 (en) * 2002-03-21 2003-10-02 Cayman Chemical Company Prostaglandin f2 alpha analogs in combinaiotn with antimicrobials for treating glaucoma
US20050058603A1 (en) 2003-05-02 2005-03-17 Case Western Reserve University Drug delivery system based on polymer nanoshells
WO2005090385A2 (en) * 2004-03-18 2005-09-29 Ansata Therapeutics, Inc. Compositions having antimicrobial activity and uses thereof
DE102007036128A1 (de) 2007-07-23 2009-02-12 Universität Leipzig Antibiotische Peptide

Also Published As

Publication number Publication date
CA2751010A1 (en) 2010-08-05
RU2011135755A (ru) 2013-03-10
ZA201105852B (en) 2013-03-27
US20150299256A1 (en) 2015-10-22
EP2391636A1 (de) 2011-12-07
US20170114096A1 (en) 2017-04-27
DE102009007381A1 (de) 2010-08-05
MX2011008030A (es) 2011-09-27
AU2010209695A1 (en) 2011-09-15
BRPI1007295A8 (pt) 2016-08-09
US20120021975A1 (en) 2012-01-26
JP2012516142A (ja) 2012-07-19
IL214365A0 (en) 2011-09-27
WO2010086401A1 (de) 2010-08-05
US8686113B2 (en) 2014-04-01
KR20110120917A (ko) 2011-11-04
EP2391636B1 (de) 2017-09-27
CN102369210A (zh) 2012-03-07

Similar Documents

Publication Publication Date Title
BRPI1007295A (pt) peptídeos antibióticos
BRPI0814587A2 (pt) Peptídeos antibióticos
PT2406399T (pt) Proteínas mirac
EP2497655A4 (en) TIRES
BRPI1013989A2 (pt) pneumático
DK2462134T3 (da) N1-sulfonyl-5-fluorpyrimidinonderivater
BRPI1011967A2 (pt) pneumático
DE112010002949A5 (de) Kupplungstastpunkte
PT2464370T (pt) Péptidos vasoativos intestinais modificados
BRPI1008827A2 (pt) deisobutenizador
BRPI1014968A2 (pt) subalargador
EP2437770A4 (en) ANTIMICROBIAL PEPTIDES
DE112010002728A5 (de) Turboinhalator
BRPI1013720A2 (pt) pneumático
EP2289713A4 (en) TIRE
DE112009005323A5 (de) Hebelarmprüfmaschine
BRPI1010661A2 (pt) peptídeo
BRPI1007884A2 (pt) derivados de actagardina
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BRPI1008070A2 (pt) tricianoboratos
BR112012004964A2 (pt) girocóptero
BRPI1008662A2 (pt) pneumático
EP2418102A4 (en) TIRE
FR2947857B1 (fr) Agencement de deshuileur
BRPI1007486A2 (pt) pneumático

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B25E Requested change of name of applicant rejected

Owner name: AMP-THERAPEUTICS GMBH AND CO. KG (DE)

B15K Others concerning applications: alteration of classification

Ipc: C07K 7/08 (2006.01), A01N 47/44 (2006.01), A61K 38

B350 Update of information on the portal [chapter 15.35 patent gazette]